Alexander Wald

1.8k total citations
8 papers, 22 citations indexed

About

Alexander Wald is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Alexander Wald has authored 8 papers receiving a total of 22 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Surgery. Recurrent topics in Alexander Wald's work include Bone health and treatments (2 papers), Immunotherapy and Immune Responses (2 papers) and Bone Metabolism and Diseases (2 papers). Alexander Wald is often cited by papers focused on Bone health and treatments (2 papers), Immunotherapy and Immune Responses (2 papers) and Bone Metabolism and Diseases (2 papers). Alexander Wald collaborates with scholars based in Germany and United States. Alexander Wald's co-authors include Ferdinand Toberer, Jörg Hennenlotter, Gunnar Blumenstock, Enno Schmidt, Kristin Rentzsch, Alexander Enk, Georgios Gakis, Arnulf Stenzl, Christian Schwentner and Jochen Hoffmann and has published in prestigious journals such as The Journal of Urology, Cancers and British Journal of Urology.

In The Last Decade

Alexander Wald

8 papers receiving 21 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Wald Germany 3 10 9 8 6 4 8 22
Xiangyu Fang China 5 7 0.7× 7 0.8× 10 1.3× 2 0.3× 4 1.0× 8 37
Catherine Huck Switzerland 3 5 0.5× 5 0.6× 4 0.5× 15 2.5× 6 1.5× 6 27
D Darabantiu Romania 2 10 1.0× 7 0.8× 3 0.4× 5 0.8× 2 32
Sacha Schweikert Australia 3 9 0.9× 19 2.1× 4 0.5× 4 0.7× 5 70
Susana Merino Spain 2 5 0.5× 9 1.0× 13 1.6× 22 3.7× 8 2.0× 3 43
Lydia Eccersley United Kingdom 3 13 1.3× 17 1.9× 3 0.4× 5 0.8× 5 1.3× 9 28
Cornel Dragan Romania 3 6 0.6× 11 1.2× 10 1.3× 4 0.7× 14 3.5× 3 22
Katarína Reguliová Czechia 2 5 0.5× 7 0.8× 11 1.4× 20 3.3× 3 25
Benjamin Carpentier France 4 4 0.4× 10 1.1× 4 0.5× 7 1.2× 11 2.8× 9 28
Havish S. Kantheti United States 2 5 0.5× 12 1.3× 5 0.6× 3 0.5× 2 19

Countries citing papers authored by Alexander Wald

Since Specialization
Citations

This map shows the geographic impact of Alexander Wald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Wald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Wald more than expected).

Fields of papers citing papers by Alexander Wald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Wald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Wald. The network helps show where Alexander Wald may publish in the future.

Co-authorship network of co-authors of Alexander Wald

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Wald. A scholar is included among the top collaborators of Alexander Wald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Wald. Alexander Wald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Salzmann, Martin, Alexander Wald, Henner Stege, et al.. (2023). Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study. Cancers. 15(5). 1426–1426. 1 indexed citations
2.
Wald, Alexander, et al.. (2022). Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma. Cancer Immunology Immunotherapy. 72(2). 509–513. 1 indexed citations
4.
Kermany, Mohammad Habiby, et al.. (2014). MP29-17 CANCER/ TESTIS ANTIGEN NY-ESO-1 - A POTENTIAL TARGET FOR IMMUNOTHERAPY IN RENAL CELL CARCINOMA (RCC). The Journal of Urology. 191(4S). 1 indexed citations
5.
Todenhöfer, Tilman, Jörg Hennenlotter, Alexander Wald, et al.. (2013). Serum receptor activator of nuclear factor κB ligand ( RANKL ) levels predict biochemical recurrence in patients undergoing radical prostatectomy. British Journal of Urology. 113(1). 152–159. 8 indexed citations
6.
Hennenlotter, Joerg, Alexander Wald, Gunnar Blumenstock, et al.. (2013). 1049 RANKL pathway proteins as risk parameters for biochemical recurrence in patients undergoing radical prostatectomy. European Urology Supplements. 12(1). e1049–e1049. 1 indexed citations
7.
Afonina, Irina, Stephen Sanders, Igor V. Kutyavin, et al.. (2002). Single nucleotide polymorphism detection with MGB Eclipse (TM) assays. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam). 25(3). 268–275. 3 indexed citations
8.
Wald, Alexander, et al.. (1996). Klinik und Epidemiologie der Arthrose. Aktuelle Rheumatologie. 21(1). 2–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026